Geneware and its partners have achieved great successes through its target identification and validation platform

Geneware has identified an old drug that targets the pathway of migraine, and is now in partnership with a pharma company for further development.

Geneware has approached the intervention of Alzheimer’s disease through an off beaten path and developed a special nutritional formulation.

Geneware has been in partnership with Tianfu Innovation Insitute of Chengdu to provide comperhensive services for due diligence analysis of drug development projects.

Geneware has partnered with a pharma company in Shenzhen, China to develop a new formulation for skin health.

Geneware has partnered with a pharma company in Shenzhen, China to develop a new formulation for vagina health.